The CHMP remains concerned about the continued supply shortages of Genzyme's medicines. It is currently assessing proposals for improvement measures put in place by Genzyme to prevent similar manufacturing and quality problems in the future, and is closely monitoring the implementation of these measures. The Agency will make further updates as appropriate.